Integra Lifesciences Holdings Corp’s filing revealed that its EVP, Chief Legal Officer & Sec Schwartz Eric unloaded Company’s shares for reported $0.1 million on Dec 03 ’24. In the deal valued at $24.59 per share,4,070 shares were sold. As a result of this transaction, Schwartz Eric now holds 59,511 shares worth roughly $0.96 million.
Then, Schwartz Eric bought 4,070 shares, generating $100,102 in total proceeds.
Before that, McBreen Michael J. sold 1,700 shares. Integra Lifesciences Holdings Corp shares valued at $41,064 were divested by the EVP & President, CSS at a price of $24.16 per share. As a result of the transaction, McBreen Michael J. now holds 56,182 shares, worth roughly $0.9 million.
Argus upgraded its Integra Lifesciences Holdings Corp [IART] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in early December with a ‘”an Underweight”‘ rating. BTIG Research also remained covering IART and has increased its forecast on October 07, 2024 with a “Neutral” recommendation from previously “Sell” rating. Citigroup revised its rating on July 30, 2024. It rated IART as “a Sell” which previously was an “a Neutral”.
Price Performance Review of IART
On Tuesday, Integra Lifesciences Holdings Corp [NASDAQ:IART] saw its stock fall -3.89% to $16.08. Over the last five days, the stock has lost -11.01%. Integra Lifesciences Holdings Corp shares have fallen nearly -29.10% since the year began. Nevertheless, the stocks have fallen -50.98% over the past one year. While a 52-week high of $33.04 was reached on 01/30/25, a 52-week low of $15.95 was recorded on 04/11/25. SMA at 50 days reached $22.23, while 200 days put it at $22.64.
Levels Of Support And Resistance For IART Stock
The 24-hour chart illustrates a support level at 15.76, which if violated will result in even more drops to 15.45. On the upside, there is a resistance level at 16.65. A further resistance level may holdings at 17.23. The Relative Strength Index (RSI) on the 14-day chart is 24.49, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.88, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.94%. Stochastics %K at 9.79% indicates the stock is a buying.
How much short interest is there in Integra Lifesciences Holdings Corp?
A steep rise in short interest was recorded in Integra Lifesciences Holdings Corp stocks on 2025-03-31, dropping by -0.6 million shares to a total of 3.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 3.91 million shares. There was a decline of -18.15%, which implies that there is a negative sentiment for the stock.
